Obesity Featured Articles

1. Why Do Clinical Trials Cost So Much? Looking Beyond The Obvious 11/5/2026

   The true cost of research goes beyond budgets to design, data, and execution inefficiencies. Streamlining processes and early decisions reduces delays, controls costs, and improves study quality.

2. CRF Validation Best Practices: Building Reliable Clinical Trial Databases 11/5/2026

   CRF validation improves data quality and efficiency. Early planning, clear edit checks, and balance reduce rework, ease site burden, and enable more reliable, streamlined study execution.

3. Why More Sponsors Are Taking Control Of Clinical Trial Study Builds 11/5/2026

   Accelerate study startup and reduce rework by building studies directly in EDC. Discover a more flexible, efficient approach to managing clinical trials and data quality.

4. Walmart's Clinical Trial Model Faces Its Real Test 11/5/2026

   Walmart and Care Access are bringing clinical trials into retail stores, but convenient locations are only part of the equation. Can this model improve recruitment, retention, and access — or simply offer a new setting for familiar research challenges?

5. A Window Into Aging: Why Skin Is the First Test For RLS-1496 11/5/2026

   Rubedo’s Marco Quarta explains how patient selection, controls, biopsies, and biomarkers shaped early RLS-1496 trial protocols.

6. RWD Into RWE: What Sponsors Need To Know For Trials 11/4/2026

   Many sponsors are hesitant to incorporate RWD and RWE into their clinical trial ecosystems. In most cases, they are still determining where these data pools fit best into their workflows. But, if applied with precision, the data from real-world healthcare scenarios derisks the effort of bringing a molecule to market.

7. Brazil's Regulatory Transformation: Building And Supporting Sites Beyond The AMCs 11/4/2026

   Our expert chat about Brazil’s clinical research transformation concludes with SBOC President-elect Fabio Franke, who explores building sustainable trial capacity beyond the country’s major AMCs.

8. Brazil's Regulatory Transformation: Expanding Clinical Trial Participation 11/3/2026

   A discussion of Brazil’s clinical research transformation continues as this Q&A series turns to Maiko L. Tonini, Ph.D., of Brazil’s Ministry of Health, to explore expanding clinical trial participation.

9. Washington's Clinical Trial Alphabet Soup 11/3/2026

   From FDA pilots to congressional proposals, Washington is taking aim at clinical trial delays, patient access barriers, and fragmented data. Dan Schell sorts through the initiatives and the practical questions that will determine whether they make a difference for sponsors, sites, and patients.

10. Clinical Trial Participants Say It's One Of Their Biggest Burdens 11/2/2026

    Travel to the study site shapes who enrolls, who stays compliant, and who completes a trial. Participant survey data shows where distance creates friction and which supports matter most.